Top

Journal of Clinical Immunology

Published in:

01-07-2021 | Chronic Inflammatory Bowel Disease | Letter to Editor

A novel 333 bp deletion of IL10RA in Chinese patients with neonatal-onset inflammatory bowel disease

Authors: Xiaomin Peng, Yulan Lu, Bingbing Wu, Xinran Dong, Wenbin Li, Huijun Wang, Ying Huang, Wenhao Zhou

Published in: Journal of Clinical Immunology | Issue 5/2021

Excerpt

To the Editor, …

Available only for authorised users

Uhlig HH, Schwerd T, Koletzko S, Shah N, Kammermeier J, Elkadri A, et al. The diagnostic approach to monogenic very early onset inflammatory bowel disease. Gastroenterology. 2014;147(5):990–1007 e3. https://doi.org/10.1053/j.gastro.2014.07.023.CrossRefPubMed

Murugan D, Albert MH, Langemeier J, Bohne J, Puchalka J, Jarvinen PM, et al. Very early onset inflammatory bowel disease associated with aberrant trafficking of IL-10R1 and cure by T cell replete haploidentical bone marrow transplantation. J Clin Immunol. 2014;34(3):331–9. https://doi.org/10.1007/s10875-014-9992-8.CrossRefPubMed

Huang Z, Peng K, Li X, Zhao R, You J, Cheng X, et al. Mutations in interleukin-10 receptor and clinical phenotypes in patients with very early onset inflammatory bowel disease: a Chinese VEO-IBD Collaboration Group Survey. Inflamm Bowel Dis. 2017;23(4):578–90. https://doi.org/10.1097/MIB.0000000000001058.CrossRefPubMed

Oh SH, Baek J, Liany H, Foo JN, Kim KM, Yang SC, et al. A synonymous variant in IL10RA affects RNA splicing in paediatric patients with refractory inflammatory bowel disease. J Crohns Colitis. 2016;10(11):1366–71. https://doi.org/10.1093/ecco-jcc/jjw102.CrossRefPubMed

Abou Tayoun AN, Pesaran T, DiStefano MT, Oza A, Rehm HL, Biesecker LG, et al. Recommendations for interpreting the loss of function PVS1 ACMG/AMP variant criterion. Hum Mutat. 2018;39(11):1517–24. https://doi.org/10.1002/humu.23626.CrossRefPubMedPubMedCentral

Hanein S, Perrault I, Gerber S, Delphin N, Benezra D, Shalev S, et al. Population history and infrequent mutations: how old is a rare mutation? GUCY2D as a worked example. Eur J Hum Genet. 2008;16(1):115–23. https://doi.org/10.1038/sj.ejhg.5201905.CrossRefPubMed

Wang H, Lu Y, Dong X, Lu G, Cheng G, Qian Y, et al. Optimized trio genome sequencing (OTGS) as a first-tier genetic test in critically ill infants: practice in China. Hum Genet. 2020;139(4):473–82. https://doi.org/10.1007/s00439-019-02103-8.CrossRefPubMed

Title: A novel 333 bp deletion of IL10RA in Chinese patients with neonatal-onset inflammatory bowel disease
Authors: Xiaomin Peng
Yulan Lu
Bingbing Wu
Xinran Dong
Wenbin Li
Huijun Wang
Ying Huang
Wenhao Zhou
Publication date: 01-07-2021
Publisher: Springer US
Keyword: Chronic Inflammatory Bowel Disease
Published in: Journal of Clinical Immunology / Issue 5/2021
Print ISSN: 0271-9142
Electronic ISSN: 1573-2592
DOI: https://doi.org/10.1007/s10875-021-00973-0

ACC 2024 Congress Coverage

Heart Failure Video

Year in Review: Heart failure and cardiomyopathies

Watch now

Watch this official video from ACC.24. Dr. Biykem Bozkurt discuss last year's major advances in heart failure and cardiomyopathies.

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

A novel 333 bp deletion of IL10RA in Chinese patients with neonatal-onset inflammatory bowel disease

Excerpt

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page

At a glance: The ONWARDS insulin icodec trials

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 5/2021

Congenital Athymia: Genetic Etiologies, Clinical Manifestations, Diagnosis, and Treatment

A Patient with X-Linked Agammaglobulinemia and COVID-19 Infection Treated with Remdesivir and Convalescent Plasma

EDA-ID: a Severe Clinical Presentation Associated with a New IKBKG Mutation

Two Novel Homozygous Mutations in Phosphoglucomutase 3 Leading to Severe Combined Immunodeficiency, Skeletal Dysplasia, and Malformations

Resolution of Persistent COVID-19 After Convalescent Plasma in a Patient with B Cell Aplasia

Phenotypical and Functional Characterization of Neutrophils in Two Pyrin-Associated Auto-inflammatory Diseases

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

Incentivised to exercise

New intervention for STEMI-related cardiogenic shock

» View more highlights on the ACC 2024 congress hub page